Targeted identification of risk and treatment of diabetic kidney disease
Nat Rev Nephrol
.
2024 Feb;20(2):75-76.
doi: 10.1038/s41581-023-00796-9.
Authors
Sarah J Glastras
1
2
3
,
Carol A Pollock
4
5
6
Affiliations
1
Renal Research Laboratory, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia.
2
North Precinct, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia.
3
Department of Diabetes, Endocrinology and Metabolism, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
4
Renal Research Laboratory, Kolling Institute of Medical Research, St Leonards, New South Wales, Australia. carol.pollock@sydney.edu.au.
5
North Precinct, Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. carol.pollock@sydney.edu.au.
6
Department of Renal Medicine, Royal North Shore Hospital, St Leonards, New South Wales, Australia. carol.pollock@sydney.edu.au.
PMID:
38040863
DOI:
10.1038/s41581-023-00796-9
No abstract available
MeSH terms
Diabetes Mellitus, Type 2*
Diabetic Nephropathies*
Disease Progression
Humans
Kidney